Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ning F. Go

A Multicenter Phase 2 Study of AMG 337 in Patients With MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Related publications

Combination Chemotherapy With Paclitaxel, Cisplatin and Fluorouracil for Patients With Advanced and Metastatic Gastric or Esophagogastric Junction Adenocarcinoma: A Multicenter Prospective Study

Chinese Journal of Cancer Research

Cancer Research

Oncology

2012

English

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients With Unresectable Esophageal and Gastroesophageal Adenocarcinoma

Journal of Thoracic Oncology

English

A Phase 3 Study of Nivolumab in Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (ATTRACTION-2): 2-Year Update Data

English

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study

Frontiers in Oncology

Cancer Research

Oncology

2020

English

A Multi-Center Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

Cancer Chemotherapy and Pharmacology

English

The Role of Pembrolizumab in the Treatment of PD-L1 Expressing Gastric and Gastroesophageal Junction Adenocarcinoma

Therapeutic Advances in Gastroenterology

Gastroenterology

2019

English

A Phase 1 Study of Oral Ridaforolimus in Pediatric Patients With Advanced Solid Tumors

Oncotarget

Oncology

2016

English

Pyloroantrectomy and Pedunculated Short Gastric-Tube Interposition in Esophageal Carcinoma Patients Associated With Early Gastric Adenocarcinoma

International Surgery

Surgery

2017

English

Expression Profiles of HER2, EGFR, MET and FGFR2 in a Large Cohort of Patients With Gastric Adenocarcinoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ning F. Go

A Multicenter Phase 2 Study of AMG 337 in Patients With MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors

Related publications

Combination Chemotherapy With Paclitaxel, Cisplatin and Fluorouracil for Patients With Advanced and Metastatic Gastric or Esophagogastric Junction Adenocarcinoma: A Multicenter Prospective Study

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients With Unresectable Esophageal and Gastroesophageal Adenocarcinoma

A Phase 3 Study of Nivolumab in Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (ATTRACTION-2): 2-Year Update Data

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study

A Multi-Center Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

The Role of Pembrolizumab in the Treatment of PD-L1 Expressing Gastric and Gastroesophageal Junction Adenocarcinoma

A Phase 1 Study of Oral Ridaforolimus in Pediatric Patients With Advanced Solid Tumors

Pyloroantrectomy and Pedunculated Short Gastric-Tube Interposition in Esophageal Carcinoma Patients Associated With Early Gastric Adenocarcinoma

Expression Profiles of HER2, EGFR, MET and FGFR2 in a Large Cohort of Patients With Gastric Adenocarcinoma